Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.

[1]  H. Ljunggren,et al.  Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells , 2015, The Journal of Immunology.

[2]  A. Flaxman,et al.  Global Distribution and Prevalence of Hepatitis C Virus Genotypes , 2014, Hepatology.

[3]  Morten Nielsen,et al.  Uncovering the Peptide-Binding Specificities of HLA-C: A General Strategy To Determine the Specificity of Any MHC Class I Molecule , 2014, The Journal of Immunology.

[4]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[5]  M. Altfeld,et al.  Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03: 04 and modulate primary natural killer cell function , 2014, AIDS.

[6]  C. Stedman,et al.  Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection. , 2014, Gastroenterology.

[7]  T. Asselah,et al.  Faldaprevir (Bi 201335), Deleobuvir (Bi 207127) and Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: Sound-C1 Final Results , 2013, Antiviral Therapy.

[8]  P. Ohashi,et al.  Natural killer cells regulate diverse T cell responses. , 2013, Trends in immunology.

[9]  B. Rehermann.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells , 2013, Nature Medicine.

[10]  Sumati Rajagopalan,et al.  Controlling natural killer cell responses: integration of signals for activation and inhibition. , 2013, Annual review of immunology.

[11]  M. Altfeld,et al.  Control of human viral infections by natural killer cells. , 2013, Annual review of immunology.

[12]  P. Parham,et al.  Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution , 2013, Nature Reviews Immunology.

[13]  M. Altfeld,et al.  HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function , 2012, Retrovirology.

[14]  Todd M. Allen,et al.  HIV-1 adaptation to NK cell mediated immune pressure , 2011, Nature.

[15]  S. Khakoo,et al.  KIR/HLA Interactions and Pathogen Immunity , 2011, Journal of biomedicine & biotechnology.

[16]  C. O’Farrelly,et al.  Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection , 2011, Proceedings of the National Academy of Sciences.

[17]  S. Kotenko,et al.  Interferon-lambda: a new addition to an old family. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[18]  G. Alexander,et al.  Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus , 2010, Hepatology.

[19]  Jacques Fellay,et al.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.

[20]  H. Wedemeyer,et al.  Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha. , 2008, The Journal of antimicrobial chemotherapy.

[21]  Lewis L Lanier,et al.  Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.

[22]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[23]  A. Moretta.  The dialogue between human natural killer cells and dendritic cells. , 2005, Current opinion in immunology.

[24]  Salim I. Khakoo,et al.  HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.

[25]  P. Parham.  NK Cells Lose Their Inhibition , 2004, Science.

[26]  S. Rowland-Jones,et al.  Recognition of HLA‐A3 and HLA‐A11 by KIR3DL2 is peptide‐specific , 2004, European journal of immunology.

[27]  P. Parham.  Immunology. NK cells lose their inhibition. , 2004, Science.

[28]  Jeffrey C. Boyington,et al.  Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand , 2000, Nature.

[29]  Eric O Long,et al.  HLA class I recognition by killer cell Ig-like receptors. , 2000, Seminars in immunology.

[30]  D. Stuart,et al.  Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. , 1999, Structure.

[31]  A. McMichael,et al.  Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised , 1995, The Journal of experimental medicine.